CNXC vs. RTO, ALLE, CART, MEDP, ULS, WPP, FTAI, STN, HQY, and GLOB
Should you be buying Concentrix stock or one of its competitors? The main competitors of Concentrix include Rentokil Initial (RTO), Allegion (ALLE), Maplebear (CART), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), FTAI Aviation (FTAI), Stantec (STN), HealthEquity (HQY), and Globant (GLOB). These companies are all part of the "business services" industry.
Concentrix vs.
Rentokil Initial (NYSE:RTO) and Concentrix (NASDAQ:CNXC) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.
Rentokil Initial has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Concentrix has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.
Rentokil Initial has higher earnings, but lower revenue than Concentrix.
Concentrix received 21 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 55.56% of users gave Concentrix an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.
9.9% of Rentokil Initial shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 3.1% of Concentrix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Concentrix has a consensus price target of $75.00, suggesting a potential upside of 40.21%. Given Concentrix's stronger consensus rating and higher probable upside, analysts plainly believe Concentrix is more favorable than Rentokil Initial.
Rentokil Initial pays an annual dividend of $0.36 per share and has a dividend yield of 1.4%. Concentrix pays an annual dividend of $1.33 per share and has a dividend yield of 2.5%. Concentrix pays out 35.8% of its earnings in the form of a dividend.
Concentrix has a net margin of 2.61% compared to Rentokil Initial's net margin of 0.00%. Concentrix's return on equity of 16.67% beat Rentokil Initial's return on equity.
In the previous week, Rentokil Initial had 9 more articles in the media than Concentrix. MarketBeat recorded 14 mentions for Rentokil Initial and 5 mentions for Concentrix. Concentrix's average media sentiment score of 1.06 beat Rentokil Initial's score of 0.06 indicating that Concentrix is being referred to more favorably in the news media.
Summary
Concentrix beats Rentokil Initial on 13 of the 19 factors compared between the two stocks.
Get Concentrix News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNXC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Concentrix Competitors List
Related Companies and Tools
This page (NASDAQ:CNXC) was last updated on 1/31/2025 by MarketBeat.com Staff